BridgeBio Oncology Therapeutics, Inc.

BBOT chart

BridgeBio Oncology Therapeutics, Inc. news

• Piper Sandler Remains a Buy on BridgeBio Oncology Therapeutics (BBOT)

  The Globe and Mail · Oct 27, 7:57 AM EDT

• BridgeBio Oncology Therapeutics, Inc. Estimates – NASDAQ:BBOT

  TradingView · Oct 23, 11:33 AM EDT

• BridgeBio Oncology Therapeutics (BBOT) Stock Price Prediction for 2026, 2030-2040

  Traders Union · Oct 23, 8:08 AM EDT

• BridgeBio (BBOT) Stock Price: Up +6.34% Today, Target $2.99 2026-10-22 - Collar Trade

  https://www.siam.in/ · Oct 22, 7:34 PM EDT

• BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  Yahoo Finance · Oct 12, 4:05 PM EDT

• BridgeBio Oncology Therapeutics (BBOT) Bets Big On A Narrower KRAS Playbook

  Yahoo Finance · Sep 12, 3:40 AM EDT

• Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use

  biopharmadive.com · Sep 11, 5:37 AM EDT

• BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers

  Yahoo Finance · Sep 8, 4:05 PM EDT

• BBOT to Participate in Upcoming Investor Healthcare Conferences

  Yahoo Finance · Sep 1, 4:05 PM EDT

• BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

  Yahoo Finance · Aug 11, 4:05 PM EDT

• Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential?

  Yahoo Finance · Jun 30, 9:06 AM EDT

• Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter

  fool.com · May 17, 2:33 PM EDT

BridgeBio Oncology Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-08
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 8-K8-K2026-06-22
• 10-Q10-Q2026-05-12
• 8-K8-K2026-05-12
• 8-K8-K2026-04-29
• DEF 14ADEF 14A2026-04-28
• 8-K8-K2026-04-23
• 8-K8-K2026-03-26
• 10-K10-K2026-03-05
• 8-K8-K2026-03-05

About BridgeBio Oncology Therapeutics, Inc.

Ticker

BBOT (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

South San Francisco, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1869105

Former names

Helix Acquisition Corp. II

Frequently asked questions